Jiandong Zhang

4PUBLICATIONS
1CO-AUTHORS
Infectious agentsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 27, 2026
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy.

Fengxue Li, Lili Qiao, Xinquan Liang

|Aug 08, 2024
Clinical efficacy and safety of immune checkpoint inhibitors plus anlotinib as secondline or subsequent therapy in extensive stage small cell lung cancer: a retrospective study.

Yanan Wu, Yan Zhang, Yuanjing Tian

|Apr 10, 2024
Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer.

Song Mi, Yunxin Yang, Xin Liu

|Nov 30, 2023
Serum ferritin level is an effective prognostic factor for lung cancer immunotherapy.

Fei Wang, Guodong Deng, Ning Liang

Pageof 1

Frequent Collaborators